AAAAAA

   
Results: 1-25 | 26-50 | 51-56
Results: 1-25/56
STRATEGIES FOR LONG-TERM PATIENT-MANAGEMENT
Authors: SAAG MS
Citation: Ms. Saag, STRATEGIES FOR LONG-TERM PATIENT-MANAGEMENT, AIDS patient care and STDs, 12(7), 1998, pp. 533-536
POTENT SUPPRESSION OF HIV-1 REPLICATION IN HUMANS BY T-20, A PEPTIDE INHIBITOR OF GP41-MEDIATED VIRUS ENTRY
Authors: KILBY JM HOPKINS S VENETTA TM DIMASSIMO B CLOUD GA LEE JY ALLDREDGE L HUNTER E LAMBERT D BOLOGNESI D MATHEWS T JOHNSON MR NOWAK MA SHAW GM SAAG MS
Citation: Jm. Kilby et al., POTENT SUPPRESSION OF HIV-1 REPLICATION IN HUMANS BY T-20, A PEPTIDE INHIBITOR OF GP41-MEDIATED VIRUS ENTRY, Nature medicine, 4(11), 1998, pp. 1302-1307
THE CHANGING FACE OF AIDS RESEARCH AND HUMAN RETROVIRUSES - A NEW FORUM TO DISPLAY YOUR ARTWORK
Authors: SAAG MS
Citation: Ms. Saag, THE CHANGING FACE OF AIDS RESEARCH AND HUMAN RETROVIRUSES - A NEW FORUM TO DISPLAY YOUR ARTWORK, AIDS research and human retroviruses, 14(9), 1998, pp. 721-721
HEALTH-RELATED QUALITY-OF-LIFE IN HIV-POSITIVE PATIENTS - VARIATIONS IN OUTCOME ACROSS INSTRUMENTS
Authors: CALL SA KLAPOW JC SAAG MS STEWART KE CENTOR RM
Citation: Sa. Call et al., HEALTH-RELATED QUALITY-OF-LIFE IN HIV-POSITIVE PATIENTS - VARIATIONS IN OUTCOME ACROSS INSTRUMENTS, Medical decision making, 18(4), 1998, pp. 467-467
EVALUATION OF CHRONIC DIARRHEA IN AIDS - A COST-EFFECTIVENESS ANALYSIS
Authors: CALL SA WILCOX CM SAAG MS HEUDEBERT GR
Citation: Sa. Call et al., EVALUATION OF CHRONIC DIARRHEA IN AIDS - A COST-EFFECTIVENESS ANALYSIS, Medical decision making, 18(4), 1998, pp. 470-470
ANTIRETROVIRAL EFFECT AND SAFETY OF ABACAVIR ALONE AND IN COMBINATIONWITH ZIDOVUDINE IN HIV-INFECTED ADULTS
Authors: SAAG MS SONNERBORG A TORRES RA LANCASTER D GAZZARD BG SCHOOLEY RT ROMERO C KELLEHER D SPREEN W LAFON S
Citation: Ms. Saag et al., ANTIRETROVIRAL EFFECT AND SAFETY OF ABACAVIR ALONE AND IN COMBINATIONWITH ZIDOVUDINE IN HIV-INFECTED ADULTS, AIDS, 12(16), 1998, pp. 203-209
CALMODULIN ANTAGONISTS INHIBIT APOPTOSIS OF CD4(-CELLS FROM PATIENTS WITH AIDS() T)
Authors: PAN G ZHOU T RADDING W SAAG MS MOUNTZ JD MCDONALD JM
Citation: G. Pan et al., CALMODULIN ANTAGONISTS INHIBIT APOPTOSIS OF CD4(-CELLS FROM PATIENTS WITH AIDS() T), Immunopharmacology, 40(2), 1998, pp. 91-103
ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1998 - UPDATED RECOMMENDATIONS OF THE INTERNATIONAL AIDS SOCIETY USA PANEL
Authors: CARPENTER CCJ FISCHL MA HAMMER SM HIRSCH MS JACOBSEN DM KATZENSTEIN DA MONTANER JSG RICHMAN DD SAAG MS SCHOOLEY RT THOMPSON MA VELLA S YENI PG VOLBERDING PA
Citation: Ccj. Carpenter et al., ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1998 - UPDATED RECOMMENDATIONS OF THE INTERNATIONAL AIDS SOCIETY USA PANEL, JAMA, the journal of the American Medical Association, 280(1), 1998, pp. 78-86
CLINICAL EFFICACY OF HIGH-DOSE ACYCLOVIR IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A METAANALYSIS OF RANDOMIZED INDIVIDUAL PATIENT DATA
Authors: IOANNIDIS JPA COLLIER AC COOPER DA COREY L FIDDIAN AP GAZZARD BG GRIFFITHS PD CONTOPOULOSIOANNIDIS DG LAU J PAVIA AT SAAG MS SPRUANCE SL YOULE MS
Citation: Jpa. Ioannidis et al., CLINICAL EFFICACY OF HIGH-DOSE ACYCLOVIR IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A METAANALYSIS OF RANDOMIZED INDIVIDUAL PATIENT DATA, The Journal of infectious diseases, 178(2), 1998, pp. 349-359
USE OF CHANGES IN PLASMA-LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA TO ASSESS THE CLINICAL BENEFIT OF ANTIRETROVIRAL THERAPY
Authors: MARSCHNER IC COLLIER AC COOMBS RW DAQUILA RT DEGRUTTOLA V FISCHL MA HAMMER SM HUGHES MD JOHNSON VA KATZENSTEIN DA RICHMAN DD SMEATON LM SPECTOR SA SAAG MS
Citation: Ic. Marschner et al., USE OF CHANGES IN PLASMA-LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA TO ASSESS THE CLINICAL BENEFIT OF ANTIRETROVIRAL THERAPY, The Journal of infectious diseases, 177(1), 1998, pp. 40-47
USE OF VIROLOGICAL MARKERS IN CLINICAL-PRACTICE
Authors: SAAG MS
Citation: Ms. Saag, USE OF VIROLOGICAL MARKERS IN CLINICAL-PRACTICE, Journal of acquired immune deficiency syndromes and human retrovirology, 16, 1997, pp. 3-13
THE EFFECT OF MODE OF ADMINISTRATION ON MEDICAL OUTCOMES STUDY HEALTHRATINGS AND EUROQOL SCORES IN AIDS
Authors: WU AW JACOBSON DL BERZON RA REVICKI DA VANDERHORST C FICHTENBAUM CJ SAAG MS LYNN L HARDY D FEINBERG J
Citation: Aw. Wu et al., THE EFFECT OF MODE OF ADMINISTRATION ON MEDICAL OUTCOMES STUDY HEALTHRATINGS AND EUROQOL SCORES IN AIDS, Quality of life research, 6(1), 1997, pp. 3-10
EFFECTS OF TAPERING DOSES OF ORAL PREDNISONE ON VIRAL LOAD AMONG HIV-INFECTED PATIENTS WITH UNEXPLAINED WEIGHT-LOSS
Authors: KILBY JM TABEREAUX PB MULANOVICH V SHAW GM BUCY RP SAAG MS
Citation: Jm. Kilby et al., EFFECTS OF TAPERING DOSES OF ORAL PREDNISONE ON VIRAL LOAD AMONG HIV-INFECTED PATIENTS WITH UNEXPLAINED WEIGHT-LOSS, AIDS research and human retroviruses, 13(17), 1997, pp. 1533-1537
ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1997 - UPDATED RECOMMENDATIONS OF THE INTERNATIONAL-AIDS-SOCIETY USA PANEL
Authors: CARPENTER CCJ FISCHL MA HAMMER SM HIRSCH MS JACOBSEN DM KATZENSTEIN DA MONTANER JSG RICHMAN DD SAAG MS SCHOOLEY RT THOMPSON MA VELLA S YENI PG VOLBERDING PA
Citation: Ccj. Carpenter et al., ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1997 - UPDATED RECOMMENDATIONS OF THE INTERNATIONAL-AIDS-SOCIETY USA PANEL, JAMA, the journal of the American Medical Association, 277(24), 1997, pp. 1962-1969
TREATMENT OF CRYPTOCOCCAL MENINGITIS - REPLY
Authors: SAAG MS CLOUD GA VANDERHORST C
Citation: Ms. Saag et al., TREATMENT OF CRYPTOCOCCAL MENINGITIS - REPLY, The New England journal of medicine, 337(21), 1997, pp. 1557-1558
TREATMENT OF CRYPTOCOCCAL MENINGITIS ASSOCIATED WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
Authors: VANDERHORST CM SAAG MS CLOUD GA HAMILL RJ GRAYBILL JR SOBEL JD JOHNSON PC TUAZON CU KERKERING T MOSKOVITZ BL POWDERLY WG DISMUKES WE RISER L THOMAS C LACKE C WHITE AC PATTERSON S DAVIS D FLANIGAN C HARDEN T PHILLIPS D ULLOM I VASQUEZ J MCMULLEN S FLOWERS D BOSHA M BRITTON M FISHER JF NEWMAN C WILLIS B HENDERSON H JOHNSON E DUNGO L PIERCE M MORGAN M STERN J PETROSKY N BAMBERGER D FARNAN R FEINBERG J APUZZO L ROYAL W THOMPSON S BARRETT K KAUFFMAN C GUTSCH H MCKINSEY D LEE B HYSLOP N GREENSPAN D STRATA R FESSEL WJ VANRAALTE G PANKEY G SCHNEIDER D BRIGGS ND PIERCE D LEE S VANGNESS I LONGMIRE B STANSELL J JACOBSON M GRAY D COLEMAN R VOORHEES J KLEBERT M ROYAL M MILDVAN D FRIEDLAND G COONEY E WALESKY M LEEDOM JM LARSEN R DIAMOND D WHEAT LJ NIXON H CRAFT J NEIDIG JL FASS RJ RUSSELL J MACGREGOR RR KAPPES R TSELIS A SKAHAN KJ JACKSON B DANIEL P PAULSONWHITE C HEWITT R COHN S LEWIS M GREISBERGER C HELLER H SUGAR A KARCHMER AW FITCH H FLAM R JOSEPH M ELSADR W SOEIRO R STEIN D ZINGMAN B POLLARD R HAUSRATH S WATERMAN K SQUIRES K PONTICELLO L GRIECO M HAFNER R DIXON D
Citation: Cm. Vanderhorst et al., TREATMENT OF CRYPTOCOCCAL MENINGITIS ASSOCIATED WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME, The New England journal of medicine, 337(1), 1997, pp. 15-21
USE OF HIV VIRAL LOAD IN CLINICAL-PRACTICE - BACK TO THE FUTURE
Authors: SAAG MS
Citation: Ms. Saag, USE OF HIV VIRAL LOAD IN CLINICAL-PRACTICE - BACK TO THE FUTURE, Annals of internal medicine, 126(12), 1997, pp. 983-985
DECREASED FAT AND NITROGEN LOSSES IN PATIENTS WITH AIDS RECEIVING MEDIUM-CHAIN-TRIGLYCERIDE-ENRICHED FORMULA VS THOSE RECEIVING LONG-CHAIN-TRIGLYCERIDE-CONTAINING FORMULA
Authors: CRAIG CB DARNELL BE WEINSIER RL SAAG MS EPPS L MULLINS L LAPIDUS WI ENNIS DM AKRABAWI SS CORNWELL PE SAUBERLICH HE
Citation: Cb. Craig et al., DECREASED FAT AND NITROGEN LOSSES IN PATIENTS WITH AIDS RECEIVING MEDIUM-CHAIN-TRIGLYCERIDE-ENRICHED FORMULA VS THOSE RECEIVING LONG-CHAIN-TRIGLYCERIDE-CONTAINING FORMULA, Journal of the American Dietetic Association, 97(6), 1997, pp. 605-611
HIV VIRAL LOAD MARKERS IN CLINICAL-PRACTICE
Authors: SAAG MS HOLODNIY M KURITZKES DR OBRIEN WA COOMBS R POSCHER ME JACOBSEN DM SHAW GM RICHMAN DD VOLBERDING PA
Citation: Ms. Saag et al., HIV VIRAL LOAD MARKERS IN CLINICAL-PRACTICE, Nature medicine, 2(6), 1996, pp. 625-629
HIV-SPECIFIC CELLULAR AND HUMORAL IMMUNE-RESPONSES IN PRIMARY HIV-INFECTION
Authors: CONNICK E MARR DG ZHANG XQ CLARK SJ SAAG MS SCHOOLEY RT CURIEL TJ
Citation: E. Connick et al., HIV-SPECIFIC CELLULAR AND HUMORAL IMMUNE-RESPONSES IN PRIMARY HIV-INFECTION, AIDS research and human retroviruses, 12(12), 1996, pp. 1129-1140
ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1996 - RECOMMENDATIONS OFAN INTERNATIONAL PANEL
Authors: CARPENTER CCJ FISCHL MA HAMMER SM HIRSCH MS JACOBSEN DM KATZENSTEIN DA MONTANER JSG RICHMAN DD SAAG MS SCHOOLEY RT THOMPSON MA VELLA S YENI PG VOLBERDING PA
Citation: Ccj. Carpenter et al., ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1996 - RECOMMENDATIONS OFAN INTERNATIONAL PANEL, JAMA, the journal of the American Medical Association, 276(2), 1996, pp. 146-154
KINETICS OF CYTOKINE EXPRESSION DURING PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: GRAZIOSI C GANTT KR VACCAREZZA M DEMAREST JF DAUCHER M SAAG MS SHAW GM QUINN TC COHEN OJ WELBON CC PANTALEO G FAUCI AS
Citation: C. Graziosi et al., KINETICS OF CYTOKINE EXPRESSION DURING PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, Proceedings of the National Academy of Sciences of the United Statesof America, 93(9), 1996, pp. 4386-4391
ASSESSMENT OF ANTIRETROVIRAL THERAPY BY PLASMA VIRAL LOAD TESTING - STANDARD AND ICD HIV-1 P24 ANTIGEN AND VIRAL-RNA (QC-PCR) ASSAYS COMPARED
Authors: KAPPES JC SAAG MS SHAW GM HAHN BH CHOPRA P CHEN QD EMINI EA MCFARLAND R YANG LC PIATAK M LIFSON JD
Citation: Jc. Kappes et al., ASSESSMENT OF ANTIRETROVIRAL THERAPY BY PLASMA VIRAL LOAD TESTING - STANDARD AND ICD HIV-1 P24 ANTIGEN AND VIRAL-RNA (QC-PCR) ASSAYS COMPARED, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 139-149
CLINICAL AND HOST DIFFERENCES BETWEEN INFECTIONS WITH THE 2 VARIETIESOF CRYPTOCOCCUS-NEOFORMANS - RESPONSE
Authors: SAAG MS
Citation: Ms. Saag, CLINICAL AND HOST DIFFERENCES BETWEEN INFECTIONS WITH THE 2 VARIETIESOF CRYPTOCOCCUS-NEOFORMANS - RESPONSE, Clinical infectious diseases, 21(1), 1995, pp. 35-36
CLINICAL-EVALUATION OF BRANCHED DNA SIGNAL AMPLIFICATION FOR QUANTIFYING HIV TYPE-1 IN HUMAN PLASMA
Authors: CAO YZ HO DD TODD J KOKKA R URDEA M LIFSON JD PIATAK M CHEN S HAHN BH SAAG MS SHAW GM
Citation: Yz. Cao et al., CLINICAL-EVALUATION OF BRANCHED DNA SIGNAL AMPLIFICATION FOR QUANTIFYING HIV TYPE-1 IN HUMAN PLASMA, AIDS research and human retroviruses, 11(3), 1995, pp. 353-361
Risultati: 1-25 | 26-50 | 51-56